“That’s definitely a possibility,” he said. “We’re not going to exit succinic acid permanently although it’s all based on demand. If we see good demand and there’s a good market then we’ll evaluate the situation at that time and make a decision if we’re going to go back to succinic acid.”
Senior HR Manager Jennifer St. Jean said as a result of the shift, about 30 employees at the Vidal Street plant have been permanently laid off.
“We’re not closing our doors,” said St. Jean. “We’ve retained a core group of professionals that will escalate the development of our new bio-based pipeline products that have reached the mature stable state in the piloting and qualification stages.”
St. Jean said the company is actively hiring for positions like executive sales staff, animal feed, fermentation and engineering scientists.
LCY Biosciences bought the plant for $4.34 million in 2019 as part of BioAmber’s court-ordered liquidation process.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.